Amato Giaccia - 03 Dec 2021 Form 4 Insider Report for Aravive, Inc.

Role
Director
Signature
/s/ Abel Svitavsky, Attorney-In-Fact
Issuer symbol
N/A
Transactions as of
03 Dec 2021
Net transactions value
$0
Form type
4
Filing time
23 Dec 2021, 16:08:24 UTC
Previous filing
02 Dec 2021
Next filing
26 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARAV Common Stock Gift $0 -48,366 -4.9% $0.000000 941,880 03 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction involved a gift of shares of common stock by the reporting person to The Denise Chan Cancer Biology Program Endowed Fund in the Stanford Cancer Institute in the School of Medicine.